References
- Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lo-Maestro BM, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315–20.
- Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, et al. Influence of vancomcycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008;46: 193–200.
- Aguado JM, San-Juan R, Lalueza A, Sanz F, Rodriguez- Otero J, Gómez-González C, et al. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerg Infect Dis 2011;17:1099–102.
- Holmes, NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O’Sullivan M, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011;204:340–7.
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hugues JM. CDC definitions for nosocomial infections,1988. Am J Infect Control1988;16:128–40.
- Clinical Laboratory and Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests: approved standard, 10th ed. CLSI document M02-A10. CLSI; 2009.
- Pillai SK, Wennersten C, Venkataraman L, Eliopoulos G, Moellering R, Karchmer A. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis 2009;49:1169–74.
- Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, et al. Cell wall thickening is a common feature of vancomycin reistance in Staphylococcus aureus. J Clin Microbiol 2003;41:5–14.
- Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Koran TM, O’Sullivan MVN, et al. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteremia. Clin Microbiol Infect 2013;19:1163–8.
- Mascitti KB, Edelstein PH, Fishman NO, Morales KH, Baltus AJ, Lautenbach E, et al. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2012; 33:160–6.
- Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical Practice Guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1–45.